2 min read

UBC’s Research Named Best Paper In Track for PharmaSug 2021

The paper “Standardizing Laboratory Data from Diverse Real-World Data was honored at the annual conference.
The paper “Standardizing Laboratory Data from Diverse Real-World Data was honored at the annual conference.

Irene Cosmatos’ and Michael Bulgrien’s paper “Standardizing Laboratory Data from Diverse Real-World Data” was recognized as the Best Paper in the Real World Evidence/Big Data track of PharmaSUG 2021.

Every year, PharmaSUG brings together life science and health research professionals focused on the applications of technical solutions in data analytics and regulatory support. During the Real World Evidence/Big Data track, UBC was honored to present our approach to standardizing diverse laboratory data from electronic medical record databases.  Diversity in the naming conventions for laboratory tests and the reporting of laboratory results presents a significant challenge for generating meaningful real-world evidence to support healthcare decision-making. UBC’s Irene Cosmatos, Senior RWD Epidemiologist, and Michael Bulgrien, Senior Data Analytics Project Manager, developed the manuscript and associated presentation based on their many years of experience in designing, implementing, and evaluating real world evidence studies using global real-world databases. The manuscript was named Best Paper in this track.

The recorded presentation is below, and you can also access the abstract here.

UBC, a technology-forward company, is proud to receive this award that recognizes our contribution to the continuously growing but complex field of healthcare data informatics.  UBC’s multidisciplinary team of epidemiologists, database specialists, outcomes researchers, clinicians, and statisticians are always striving to improve the approaches to RWD evaluation that can generate valuable insights into disease understanding and improved patient care. To learn more about UBC’s approach to identify the right data for the right purpose and the leading technology infrastructure that powers our studies, head here.

Other Recent Posts

Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
Press
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
Press
3 min read

UBC Recognized as a Citeline Awards Finalist Again

The Citeline Awards have recognized UBC & Seqster’s innovative collaboration as a shortlisted finalist for the Best Patient-Facing Technology Initiative Category in 2023.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.